(Q46694927)

24 December 2017

title

Cost effectiveness of dalteparin for preventing venous thromboembolism in abdominal surgery (English)

1 reference

24 December 2017

main subject

venous thromboembolism

1 reference

Adrienne Heerey

1

1 reference

24 December 2017

Sanjeev Suri

series ordinal

2

1 reference

24 December 2017

publication date

1 January 2005

1 reference

24 December 2017

published in

PharmacoEconomics

1 reference

24 December 2017

volume

23

1 reference

24 December 2017

issue

9

1 reference

24 December 2017

page(s)

927-944

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.2165/00019053-200523090-00005

exact match

0 references

cites work

Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin

1 reference

12 December 2020

Prophylaxis of thromboembolism in general surgery: comparison between standard heparin and Fragmin.

1 reference

12 December 2020

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

12 December 2020

Major bleeding after hospitalization for deep-venous thrombosis.

1 reference

12 December 2020

Cost of Long-Term Complications of Deep Venous Thrombosis of the Lower Extremities: An Analysis of a Defined Patient Population in Sweden

1 reference

12 December 2020

Automated computer interviews to elicit utilities: potential applications in the treatment of deep venous thrombosis

1 reference

12 December 2020

Handling uncertainty in cost-effectiveness models

1 reference

12 December 2020

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

1 reference

12 December 2020

Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery

1 reference

12 December 2020

Prevention of venous thromboembolism

1 reference

12 December 2020

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group

1 reference

12 December 2020

Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors

1 reference

12 December 2020

Thromboembolic prophylaxis in moderate-risk patients undergoing elective abdominal surgery: decision and cost-effectiveness analyses

1 reference

12 December 2020

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors.

1 reference

12 December 2020

Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis

1 reference

12 December 2020

A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. A French multicenter trial

1 reference

12 December 2020

Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients

1 reference

12 December 2020

An introduction to Markov modelling for economic evaluation

1 reference

12 December 2020

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials

1 reference

12 December 2020

10.2165/00019053-200523090-00005

Identifiers

DOI

1 reference

24 December 2017

Dimensions Publication ID

1026576513

0 references

1 reference

24 December 2017